Celltrion
068270.KS
#755
Rank
โ‚น2.931 T
Marketcap
โ‚น13,401
Share price
1.40%
Change (1 day)
31.55%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น171.00. In 2024 the company made an earnings per share (EPS) of โ‚น121.18 a decrease over its 2023 EPS that were of โ‚น240.29.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น165.1036.25%
2024โ‚น121.18-49.57%
2023โ‚น240.29-2.08%
2022โ‚น245.39-11.72%
2021โ‚น277.972.03%
2020โ‚น272.4382.8%
2019โ‚น149.0318.31%
2018โ‚น125.96-36.33%
2017โ‚น197.85161.25%
2016โ‚น75.732.86%
2015โ‚น73.6317.84%
2014โ‚น62.485.87%
2013โ‚น59.01-70.85%
2012โ‚น202.45134.09%
2011โ‚น86.4843.59%
2010โ‚น60.2374.49%
2009โ‚น34.52317.8%
2008โ‚น8.26-71.7%
2007โ‚น29.19